FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285678959> ?p ?o ?g. }

• W4285678959 endingPage "101684" @default.
• W4285678959 startingPage "101684" @default.
• W4285678959 abstract "Acromegaly is a chronic disease with an increased mortality in case of persistently active disease. The treatment of acromegaly is mainly based on the surgical resection of the GH secreting pituitary tumor and, in cases with persistent disease, on the medical therapy with first generation somatostatin analogues (first gen-SSAs). Data from national registries, meta-analysis and epidemiology studies showed that 24%-65% of acromegaly patients treated with first gen-SSA did not reach the control of disease, requiring second line therapies, as the second gen-SSAs and the GH receptor antagonist. According to the high efficacy of these treatments and their molecular mechanisms of action, the choice of second line therapies should be personalized. In this review, we summarize the evidence on clinical, molecular and morphological aspects that may predict the response to second line therapies, in order to integrate and translate in the clinical practice for a patient-tailored therapeutic approach." @default.
• W4285678959 created "2022-07-17" @default.
• W4285678959 creator A5009288098 @default.
• W4285678959 creator A5044053354 @default.
• W4285678959 creator A5049553183 @default.
• W4285678959 creator A5069954158 @default.
• W4285678959 creator A5087343135 @default.
• W4285678959 creator A5088220553 @default.
• W4285678959 date "2022-12-01" @default.
• W4285678959 modified "2023-09-30" @default.
• W4285678959 title "Second line treatment of acromegaly: Pasireotide or Pegvisomant?" @default.
• W4285678959 cites W1717498144 @default.
• W4285678959 cites W1969427273 @default.
• W4285678959 cites W1969570257 @default.
• W4285678959 cites W1976654629 @default.
• W4285678959 cites W1983950740 @default.
• W4285678959 cites W1986480183 @default.
• W4285678959 cites W1993567990 @default.
• W4285678959 cites W1996943463 @default.
• W4285678959 cites W1999552666 @default.
• W4285678959 cites W2000324027 @default.
• W4285678959 cites W2014622019 @default.
• W4285678959 cites W2015166415 @default.
• W4285678959 cites W2018931885 @default.
• W4285678959 cites W2021983698 @default.
• W4285678959 cites W2022695623 @default.
• W4285678959 cites W2026824021 @default.
• W4285678959 cites W2047894687 @default.
• W4285678959 cites W2050853712 @default.
• W4285678959 cites W2053578362 @default.
• W4285678959 cites W2059251711 @default.
• W4285678959 cites W2062054706 @default.
• W4285678959 cites W2073150765 @default.
• W4285678959 cites W2079774691 @default.
• W4285678959 cites W2080232093 @default.
• W4285678959 cites W2097427207 @default.
• W4285678959 cites W2098511103 @default.
• W4285678959 cites W2098580479 @default.
• W4285678959 cites W2101992531 @default.
• W4285678959 cites W2107724413 @default.
• W4285678959 cites W2108609202 @default.
• W4285678959 cites W2112764694 @default.
• W4285678959 cites W2120166425 @default.
• W4285678959 cites W2139926910 @default.
• W4285678959 cites W2141667495 @default.
• W4285678959 cites W2143791513 @default.
• W4285678959 cites W2147795491 @default.
• W4285678959 cites W2151391578 @default.
• W4285678959 cites W2153200944 @default.
• W4285678959 cites W2155465680 @default.
• W4285678959 cites W2158629056 @default.
• W4285678959 cites W2172067681 @default.
• W4285678959 cites W2223220326 @default.
• W4285678959 cites W2286296536 @default.
• W4285678959 cites W2319849986 @default.
• W4285678959 cites W2479442657 @default.
• W4285678959 cites W2528370741 @default.
• W4285678959 cites W2621969338 @default.
• W4285678959 cites W2745584046 @default.
• W4285678959 cites W2746413353 @default.
• W4285678959 cites W2750649250 @default.
• W4285678959 cites W2776104508 @default.
• W4285678959 cites W2784845668 @default.
• W4285678959 cites W2790986661 @default.
• W4285678959 cites W2808199205 @default.
• W4285678959 cites W2883529413 @default.
• W4285678959 cites W2885388694 @default.
• W4285678959 cites W2889103264 @default.
• W4285678959 cites W2895716383 @default.
• W4285678959 cites W2896374184 @default.
• W4285678959 cites W2921558434 @default.
• W4285678959 cites W2921832518 @default.
• W4285678959 cites W2952196386 @default.
• W4285678959 cites W2972922135 @default.
• W4285678959 cites W2981041697 @default.
• W4285678959 cites W2989008389 @default.
• W4285678959 cites W3004665215 @default.
• W4285678959 cites W3009711324 @default.
• W4285678959 cites W3012988984 @default.
• W4285678959 cites W3094671238 @default.
• W4285678959 cites W3134187993 @default.
• W4285678959 cites W3137557966 @default.
• W4285678959 cites W3154217181 @default.
• W4285678959 cites W3159008004 @default.
• W4285678959 cites W3164420517 @default.
• W4285678959 cites W3197976994 @default.
• W4285678959 cites W3203914138 @default.
• W4285678959 doi "https://doi.org/10.1016/j.beem.2022.101684" @default.
• W4285678959 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35931640" @default.
• W4285678959 hasPublicationYear "2022" @default.
• W4285678959 type Work @default.
• W4285678959 citedByCount "8" @default.
• W4285678959 countsByYear W42856789592022 @default.
• W4285678959 countsByYear W42856789592023 @default.
• W4285678959 crossrefType "journal-article" @default.
• W4285678959 hasAuthorship W4285678959A5009288098 @default.
• W4285678959 hasAuthorship W4285678959A5044053354 @default.
• W4285678959 hasAuthorship W4285678959A5049553183 @default.

• next